Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide-Reference-Cited by-同舟云学术

Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide

Published:1991-06 Issue:6 Volume:21 Page:1523-1527
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Heeg Klaus,Kuon Wolfgang,Wagner Hermann

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference26 articles.

1. Antigen-Presenting Function of the Macrophage

2. Introduction of soluble protein into the class I pathway of antigen processing and presentation

3. Induction, Control and Consequences of Virus Specific Cytotoxic T Cells

4. CD8+ T lymphocytes in intracellular microbial infections

5. Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spray dried cubosomes with ovalbumin and Quil-A as a nanoparticulate dry powder vaccine formulation;International Journal of Pharmaceutics;2018-10

2. Immunogenicity of Two FMDV Nonameric Peptides Encapsulated in Liposomes in Mice and the Protective Efficacy in Guinea Pigs;PLoS ONE;2013-07-09

3. Functionalization of immunostimulating complexes (ISCOMs) with lipid vinyl sulfones and their application in immunological techniques and therapy;International Journal of Nanomedicine;2012-12

4. Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems;Journal of Liposome Research;2011-12-22

5. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses;International Journal of Pharmaceutics;2011-07